Andrew H. Reiter

ORCID: 0000-0003-1406-4913
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epigenetics and DNA Methylation
  • Cancer-related gene regulation
  • Mass Spectrometry Techniques and Applications
  • Bioactive Compounds and Antitumor Agents
  • Metabolomics and Mass Spectrometry Studies
  • Cancer Genomics and Diagnostics
  • Genomics and Chromatin Dynamics
  • Histone Deacetylase Inhibitors Research
  • Signaling Pathways in Disease
  • RNA Research and Splicing
  • Cancer therapeutics and mechanisms
  • Advanced Proteomics Techniques and Applications

Broad Institute
2022-2025

Eli and Edythe Broad Foundation
2024

Abstract KMT2C and KMT2D , encoding histone H3 lysine 4 methyltransferases, are among the most commonly mutated genes in triple-negative breast cancer (TNBC). However, how these mutations may shape epigenomic transcriptomic landscapes to promote tumorigenesis is largely unknown. Here we describe that deletion of Kmt2c or Kmt2d non-metastatic murine models TNBC drives metastasis, especially brain. Global chromatin profiling immunoprecipitation followed by sequencing revealed altered H3K4me1,...

10.1038/s41556-024-01446-3 article EN cc-by Nature Cell Biology 2024-06-26

Despite the widespread use of MS for hydrogen/deuterium exchange measurements, no systematic, large-scale study has been conducted to compare observed rates in protein-derived, unstructured peptides measured by predicted calculated from NMR-derived values and how neighboring residues post-translational modifications influence those rates. In this study, we sought test accuracy performing hydrogen measurements on whole cell digests generate an unbiased dataset 563 unique derived...

10.1016/j.mcpro.2025.100904 article EN cc-by Molecular & Cellular Proteomics 2025-01-01
Coming Soon ...